Skip to main content
SpringerLink
Log in

Diagnosis and Management of Valvular Heart Disease

  • Chapter
  • First Online:
Cardiology Consult Manual

Abstract

As the total population has been increasingly aging, the prevalence of valvular heart disease has increased to a level where it is now responsible for 10–20% of cardiac surgeries in the United States (Maganti et al., Mayo Clin Proc 85(5):483–500, 2010). Recent years have brought a remarkable improvement in the clinical outcome of patients with valvular heart disease. Our goal in this chapter is to highlight critical issues when evaluating these patients, including etiology and severity of valvular disease, presence or absence of symptoms, relationship of symptoms and prognosis in valvular disease, and risk-benefit ratio of possible interventions. Finally, we will provide the latest guidelines for treatment including surgical consultation and transcatheter interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Arora S, Misenheimer JA, Ramaraj R. Transcatheter aortic valve replacement: comprehensive review and present status. Tex Heart Inst J. 2017;44(1):29–38.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Otto C, Bonow R. Valvular heart disease. In: Mann DL, Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Braunwald‘s heart disease: a textbook of cardiovascular medicine. 10th ed. Philadelphia: Elsevier Saunders; 2015. p. 1446–523.

    Google Scholar 

  3. Maganti K, et al. Valvular heart disease: diagnosis and management. Mayo Clin Proc. 2010;85(5):483–500.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009;373(9667):956–66.

    Article  PubMed  Google Scholar 

  5. Grimard BH, Safford RE, Burns EL. Aortic stenosis: diagnosis and treatment. Am Fam Physician. 2016;93(5):371–8.

    PubMed  Google Scholar 

  6. Ross J Jr, Braunwald E. Aortic stenosis. Circulation. 1968;38(1 Suppl):61–7.

    PubMed  Google Scholar 

  7. Warkentin TE, Moore JC, Morgan DG. Gastrointestinal angiodysplasia and aortic stenosis. N Engl J Med. 2002;347(11):858–9.

    Article  PubMed  Google Scholar 

  8. Vincentelli A, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349(4):343–9.

    Article  PubMed  Google Scholar 

  9. Nishimura RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57–185.

    Article  PubMed  Google Scholar 

  10. Nishimura RA, Carabello BA. Hemodynamics in the Cardiac Catheterization Laboratory of the 21st Century. Circulation. 2012;125(17):2138–50.

    Article  PubMed  Google Scholar 

  11. Tribouilloy C, et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol. 2009;53(20):1865–73.

    Article  PubMed  Google Scholar 

  12. Baumgartner H, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(4):372–92.

    Article  PubMed  Google Scholar 

  13. Rossebo AB, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359(13):1343–56.

    Article  PubMed  Google Scholar 

  14. Nishimura RA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70(2):252–89.

    Article  PubMed  Google Scholar 

  15. Lytvyn L, et al. Patient values and preferences on transcatheter or surgical aortic valve replacement therapy for aortic stenosis: a systematic review. BMJ Open. 2016;6(9):e014327.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Mack MJ, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310(19):2069–77.

    Article  CAS  PubMed  Google Scholar 

  17. Bonow RO, et al. Management strategies and future challenges for aortic valve disease. Lancet. 2016;387(10025):1312–23.

    Article  PubMed  Google Scholar 

  18. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–96.

    Article  Google Scholar 

  19. Otto CM, et al. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2017;69(10):1313–46.

    Article  PubMed  Google Scholar 

  20. Singh JP, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83(6):897–902.

    Article  CAS  PubMed  Google Scholar 

  21. Enriquez-Sarano M, Tajik AJ. Clinical practice. Aortic regurgitation. N Engl J Med. 2004;351(15):1539–46.

    Article  CAS  PubMed  Google Scholar 

  22. American College of Cardiology, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48(3):e1–148.

    Article  Google Scholar 

  23. Bonow RO, et al. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation. 1991;84(4):1625–35.

    Article  CAS  PubMed  Google Scholar 

  24. Athappan G, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61(15):1585–95.

    Article  PubMed  Google Scholar 

  25. Gotzmann M, Lindstaedt M, Mugge A. From pressure overload to volume overload: aortic regurgitation after transcatheter aortic valve implantation. Am Heart J. 2012;163(6):903–11.

    Article  PubMed  Google Scholar 

  26. Kodali SK, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366(18):1686–95.

    Article  CAS  PubMed  Google Scholar 

  27. Stout KK, Verrier ED. Acute valvular regurgitation. Circulation. 2009;119(25):3232–41.

    Article  PubMed  Google Scholar 

  28. Myerson SG, et al. Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome. Circulation. 2012;126(12):1452–60.

    Article  PubMed  Google Scholar 

  29. Zoghbi WA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303–71.

    Article  PubMed  Google Scholar 

  30. Baumgartner H, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017;28(36):2739–91.

    Article  Google Scholar 

  31. Sawaya FJ, et al. Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an International Registry Study. JACC Cardiovasc Interv. 2017;10(10):1048–56.

    Article  PubMed  Google Scholar 

  32. Iung B, Vahanian A. Epidemiology of acquired valvular heart disease. Can J Cardiol. 2014;30(9):962–70.

    Article  PubMed  Google Scholar 

  33. Ray R, Chambers J. Mitral valve disease. Int J Clin Pract. 2014;68(10):1216–20.

    Article  CAS  PubMed  Google Scholar 

  34. Chandrashekhar Y, Westaby S, Narula J. Mitral stenosis. Lancet. 2009;374(9697):1271–83.

    Article  CAS  PubMed  Google Scholar 

  35. Remenyi B, et al. Valvular aspects of rheumatic heart disease. Lancet. 2016;387(10025):1335–46.

    Article  PubMed  Google Scholar 

  36. Wilkins GT, et al. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60(4):299–308.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Jones EC, et al. Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study). Am J Cardiol. 2001;87(3):298–304.

    Article  CAS  PubMed  Google Scholar 

  38. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373(9672):1382–94.

    Article  PubMed  Google Scholar 

  39. Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation: implications for management. Circulation. 2008;118(22):2298–303.

    Article  PubMed  Google Scholar 

  40. Vesely MR, et al. Surgical and transcatheter mitral valve repair for severe chronic mitral regurgitation: a review of clinical indications and patient assessment. J Am Heart Assoc. 2015;4(12).

    Google Scholar 

  41. Handa N, et al. Outcome of valve repair and the Cox maze procedure for mitral regurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg. 1999;118(4):628–35.

    Article  CAS  PubMed  Google Scholar 

  42. Herrmann HC, Maisano F. Transcatheter therapy of mitral regurgitation. Circulation. 2014;130(19):1712–22.

    Article  PubMed  Google Scholar 

  43. Michler RE, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374(20):1932–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Goldstein D, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374(4):344–53.

    Article  CAS  PubMed  Google Scholar 

  45. Kelley C, et al. Percutaneous mitral valve repair: a new treatment for mitral regurgitation. Indian Heart J. 2016;68(3):399–404.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Feldman T, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015;66(25):2844–54.

    Article  PubMed  Google Scholar 

  47. De Bonis M, et al. Optimal results immediately after MitraClip therapy or surgical edge-to-edge repair for functional mitral regurgitation: are they really stable at 4 years? Eur J Cardiothorac Surg. 2016;50(3):488–94.

    Article  PubMed  Google Scholar 

  48. Pighi M, et al. Immediate and 12-month outcomes of ischemic versus nonischemic functional mitral regurgitation in patients treated with MitraClip (from the 2011 to 2012 Pilot Sentinel Registry of Percutaneous Edge-To-Edge Mitral Valve Repair of the European Society of Cardiology). Am J Cardiol. 2017;119(4):630–7.

    Article  PubMed  Google Scholar 

  49. Zoghbi WA, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography‘s Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2009;22(9):975–1014; quiz 1082-4.

    Article  PubMed  Google Scholar 

  50. Bourguignon T, et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations. J Thorac Cardiovasc Surg. 2014;148(5):2004–11. e1

    Article  PubMed  Google Scholar 

  51. Puskas J, et al. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. J Thorac Cardiovasc Surg. 2014;147(4):1202–10; discussion 1210–1.

    Article  PubMed  Google Scholar 

  52. Capodanno D, et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017;52(3):408–17.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Texas Health Sience Center/Cardiology, Houston, TX, USA

    Katia Bravo-Jaimes

  2. University of Rochester Medical Center/Internal Medicine, Rochester, NY, USA

    Sinan Tankut

  3. University of Rochester Medical Center/Cardiology, Rochester, NY, USA

    Hanna Z. Mieszczanska

Authors
  1. Katia Bravo-Jaimes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sinan Tankut
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hanna Z. Mieszczanska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katia Bravo-Jaimes .

Editor information

Editors and Affiliations

  1. School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA

    Hanna Z. Mieszczanska

  2. Division of Cardiovascular Medicine-EP section, SUNY Downstate Medical Center, Brooklyn, NY, USA

    Adam S. Budzikowski

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bravo-Jaimes, K., Tankut, S., Mieszczanska, H.Z. (2018). Diagnosis and Management of Valvular Heart Disease. In: Mieszczanska, H., Budzikowski, A. (eds) Cardiology Consult Manual. Springer, Cham. https://doi.org/10.1007/978-3-319-89725-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-89725-7_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-89724-0

  • Online ISBN: 978-3-319-89725-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation